Healthcare IB vs Biotech ER...OR GO BUYSIDE FIG?

Hi everyone,

I'm 1.5 years into a job in ER covering FIG. Do you think it would be more realistic for me to break into healthcare IB or biotech equity research? I have access to friends who are working in both. I also have WSP courses on healthcare IB, healthcare PE guides, and access to sell-side biotech reports and models. I'd like to maximize my pay and seniority at all levels. Given that I am currently 24 years old and in a comfortable spot, I would like to work for a high ranked II team or a top healthcare banking group.

Having worked in research, I've spoken to some senior biotech analyst and associates at other banks and feel comfortable engaging them. However, I never interviewed for banking and am not sure what to bring to the table; When I reach out to people in ER, I send report and model samples. I don't think if there is an IB equivalent to show I know my stuff.

Alternatively, I suppose I could start recruiting for buyside FIG roles or switch to FIG banking. My hesitation with staying in FIG is that I know my MD makes ~500K, whereas biotech MDs make $1-4M according to some articles. Banking opens the door to PE and seems to be more lucrative than research.

Any and all feedback is appreciated, and I'm happy to answer questions about my background if it would be helpful to anyone.

 

All of the top biotech ER analysts have an MD or a PhD. Very difficult to get to that level without one of those degrees due to the complexity of the work. In healthcare IB, you need far less knowledge of underlying biology to succeed. Probably the most realistic route if you're set on heatlhcare

 

OP here. Thanks for the input. I used to think that first part too. I'm personally speaking with a biotech MD with no advance degrees and an econ undergrad degree, so I think it's possible. I've also spoken with a biotech MD who said he/she hasn't taken a science class since HS. Both of them are top 10 II analysts.

My question is, if biotech ER is harder to get into, is the field lucrative enough in terms of exits/comp to warrant that?

 

Most of the guaranteed $3-4 million contracts are coming from people with advanced degrees and years of being number 1 or 2 on the street. More of the exception than the rule. It also has a bit to do with what vertical of biotech research you are in to be fair. I am not really sure about comp unfortunately at the lower levels or even the non-top tier of biotech ER MDs. As far as exits, an analyst with a strong track record in biotech is worth his weight in gold on the buyside.

 
Most Helpful

Just my thoughts from what I’ve heard from friends and coworkers. I think you’re pointing to the exceptions of those who don’t have an advanced science degree. Yes, it is possible to still move without an advanced science degree, but you have to prove yourself to the respective hiring analysts.

As for the quoted $1-4M comp you’ve probably read from the WSJ article, those are for the reputable analysts, where the banks had to offer a huge salary to build out those franchises. Those analysts don’t really leave because their exit opp is another bank that’ll hire them. At the associate level, salaries are pretty standardized. Maybe you get a higher bonus for helping attract biotech banking deals, but that’s uncertain. I would say your main exit opp is a HC fund just because it’s a niche sector, but I don’t know how much differently they would weight biotech ER compared to HC banking.

 

Consequatur ea aliquam ipsa in voluptas molestiae omnis velit. Ea at provident commodi non sit fugit. Vel sint nostrum eaque cum.

Quo autem et sequi corrupti. Ut quos maxime sit sint necessitatibus aut. Impedit provident voluptatem repellendus nam.

Quo ex odio expedita hic deleniti. Nesciunt facilis hic ab tempora. Nemo ea omnis velit voluptatem qui ratione.

Career Advancement Opportunities

April 2024 Investment Banking

  • Jefferies & Company 02 99.4%
  • Goldman Sachs 19 98.8%
  • Harris Williams & Co. New 98.3%
  • Lazard Freres 02 97.7%
  • JPMorgan Chase 03 97.1%

Overall Employee Satisfaction

April 2024 Investment Banking

  • Harris Williams & Co. 18 99.4%
  • JPMorgan Chase 10 98.8%
  • Lazard Freres 05 98.3%
  • Morgan Stanley 07 97.7%
  • William Blair 03 97.1%

Professional Growth Opportunities

April 2024 Investment Banking

  • Lazard Freres 01 99.4%
  • Jefferies & Company 02 98.8%
  • Goldman Sachs 17 98.3%
  • Moelis & Company 07 97.7%
  • JPMorgan Chase 05 97.1%

Total Avg Compensation

April 2024 Investment Banking

  • Director/MD (5) $648
  • Vice President (19) $385
  • Associates (87) $260
  • 3rd+ Year Analyst (14) $181
  • Intern/Summer Associate (33) $170
  • 2nd Year Analyst (66) $168
  • 1st Year Analyst (205) $159
  • Intern/Summer Analyst (146) $101
notes
16 IB Interviews Notes

“... there’s no excuse to not take advantage of the resources out there available to you. Best value for your $ are the...”

Leaderboard

1
redever's picture
redever
99.2
2
BankonBanking's picture
BankonBanking
99.0
3
Betsy Massar's picture
Betsy Massar
99.0
4
Secyh62's picture
Secyh62
99.0
5
kanon's picture
kanon
98.9
6
dosk17's picture
dosk17
98.9
7
CompBanker's picture
CompBanker
98.9
8
GameTheory's picture
GameTheory
98.9
9
bolo up's picture
bolo up
98.8
10
DrApeman's picture
DrApeman
98.8
success
From 10 rejections to 1 dream investment banking internship

“... I believe it was the single biggest reason why I ended up with an offer...”